Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1R69
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,623
Award facts
- Contract value 100% obligated
- $27,623.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a contract ceiling value of $27,623.38. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance location for this delivery order is its corporate office in Conshohocken, PA. This contract represents part of AmerisourceBergen's extensive portfolio of federal medical product deliveries across multiple therapeutic domains, which demonstrates the company's capability to fulfill federal healthcare supply requirements through open competition. The DLA's Pharmaceutical Prime Vendor Global Program Generation V is expected to make multiple awards across separate regions, positioning companies like AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1R69?
SPE2DR26F1R69 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F1R69 worth?
The government has obligated $27,623 on SPE2DR26F1R69.
Is contract SPE2DR26F1R69 an order under another contract?
Yes. SPE2DR26F1R69 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1R69 competed?
The extent of competition for SPE2DR26F1R69 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award